Сравнение диагностической ценности диффузионно-взвешенной магнитно-резонансной томографии, позитронно-эмиссионной томографии с 18F-ФДГ и компьютерной томографии всего тела при метастатическом раке молочной железы
Аннотация
Об авторах
П. Б. Гележе
ГБУЗ «Научно-практический клинический центр диагностики и телемедицинских технологий Департамента здравоохранения города Москвы»
Россия
Россия
С. П. Морозов
ГБУЗ «Научно-практический клинический центр диагностики и телемедицинских технологий Департамента здравоохранения города Москвы»
Россия
Россия
Список литературы
1. Dresen R., De Vuysere S., De Keyzer F. et al. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases // Cancer Imag. 2019. № 19:1.
2. Han S., Amant F., Michielsen K. et al. Feasibility of whole body diffusion-weighted MRI for detection of primary tumour, nodal and distant metastases in women with cancer during pregnancy: a pilot study // J. Magn. Reson. Imag. 2017. № 46 (6). P. 1707-1717.
3. Heusner T., Kuemmel S., Koeninger A. et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI compared to FDG PET/CT for whole-body breast cancer staging // Eur. J. of Nucl. Med. and Mol. Imag. 2010. № 6. P. 1077-1086.
4. Jung N., Kim H., Jung J. et al. Restaging the axilla after neo-adjuvant chemotherapy for breast cancer: Predictive factors for residual metastatic lymph node disease with negative imaging findings // Breast J. 2019. № 25 (2). P. 196-201.
5. Kitajima K., Yamano T., Miyoshi Yu. et al. Prognostic value of 18F-FDG PET/CT prior to breast cancer treatment. Comparison with magnetic resonance spectroscopy and diffusion weighted imaging // Hell. J. Nucl. Med. 2019. № 22(1). P. 25-35.
6. Kosmin M., Priya V., Mei-Lin A. et al. The addition of whole body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer // Eur. J. of Cancer. № 77. P. 109-116.
7. Kwee T., Takahara T., Ochiai R. et al. Whole body diffusion-weighted magnetic resonance imaging // Eur. J. Radiol. 2009. № 70 (3). P. 409-417.
8. Li B., Li Q., Nie W. et al. Diagnostic value of whole body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis // Eur. J. Radiol. 2014. № 83 (2). P. 338-344.
9. Liu B., Gao S., Li S. A. Comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion weighted imaging-MRI for detecting the lymph nodes metastases in patients with cervical cancer: a meta-analysis based on 67 studies // Gynecol. Obstet. Invest. 2017. № 82 (3). P. 209-222.
10. Morone M., Bali M., Tunariu N. et al. Whole body MRI: current applications in oncology // Am. J. Roentgenol. 2017. № 209(6). P. 336-349.
11. Ohno Y., Yoshikawa T., Kishida Y. et al. Diagnostic performance of different imaging modalities in the assessment of distant metastasis and local recurrence of tumor in patients with non-small cell lung cancer // Eur. Radiol. 2018. № 28 (5). P. 1862-1874.
12. Orsaria P., Chiaravalloti A., Caredda E. et al. Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer // Anticancer Res. 2018. № 38 (12). P. 6639-6652.
13. Paruthikunnan S., Kadavigere R., Karegowda L. Accuracy of whole-body dwi for metastases screening in a diverse group of malignancies: comparison with conventional cross-sectional imaging and nuclear scintigraphy // Am. J. Roentgenol. 2017. № 209 (3). P. 477-490.
14. Rezk M., Nasr I., Ali I. et al. Comparative study between 18F FDG-PET/CT and whole body MRI DWIBS in assessment of recurrent breast cancer (prospective, comparative, cross-sectional study design // Ind. J. of Nucl. Med. 2019. № 34 (1). P. 1-9.
15. Schaarschmidt B., Buchbender C., Nensa F. et al. Correlation of the apparent diffusion coefficient (ADC. with the standardized uptake value (SUV in lymph node metastases of non-small cell lung cancer (NSCLC. patients using hybrid 18F-FDG PET/MRI // PLoS One. 2015. № 10 (1). P. 1-14.
16. Shen G., Ma H., Liu B. et al. Diagnostic Performance of DWI with multiple parameters for assessment and characterization of pulmonary lesions: a meta-analysis // Am. J. of Roentgenol. 2017. № 210. P. 1-10.
17. Xing H., Song C., Li W. Meta-analysis of lymph node metastasis of breast cancer patients: Clinical value of DWI and ADC value // Eur. J. Radiol. 2016. № 85 (60). P. 1132-1137.
Рецензия
Для цитирования:
Гележе П.Б., Морозов С.П. Сравнение диагностической ценности диффузионно-взвешенной магнитно-резонансной томографии, позитронно-эмиссионной томографии с 18F-ФДГ и компьютерной томографии всего тела при метастатическом раке молочной железы. Радиология – практика. 2019;(6):8-20.
For citation:
Gelezhe P.B., Morozov S.P. Comparison of the Diagnostic Value of Whole-body MRI with Diffusion-weighted Images, 18F-FDG Positron Emission Tomography Combined with Computer Tomography and Whole Body Computer Tomography in Metastatic Breast Cancer. Radiology - Practice. 2019;(6):8-20. (In Russ.)
Просмотров: 161
Послать статью по эл. почте 